@concordbiotech

@concordbiotech has been a member of Linktree for 5 years and joined in August 2021. The social media accounts linked to from @concordbiotech are: • Instagram Besides social media accounts, concordbiotech has populated their site with: • Perioperative management with DMARDs in rheumatic diseases: a scoping review of clinical guidelines - Conquest Health • Creation of New Antimicrobial Peptides 3: Research Promises and Shortcomings - Incacare • Time-dependent diffusion MRI: clinical potential in renal transplantation - Conquest Health • Exploring the Role of Extracorporeal Photopheresis in Kidney Transplant Management - Conquest Health • Asian Pacific Journal of Tropical Medicine • Immunothrombosis in Sepsis: Cellular Crosstalk, Molecular Triggers and Therapeutic Opportunities - Incacare • Optimal antibiotic use in the intensive care unit - Incacare • Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets - Conquest Health • Guidelines for the use of lung ultrasound to optimise the management of neonatal respiratory distress: international expert consensus - Incacare • How AI can help in error detection and prevention in the ICU? - Incacare • Rapid Response with Daratumumab for Pure Red Cell Aplasia in a Case of Aplastic Anemia with Mixed Chimerism After ABO-Mismatched Stem Cell Transplant - Conquest Health • Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM - Incacare • New β-Lactam/β-Lactamase Inhibitor Combination Antibiotics - Incacare • Indications and Long-Term Outcomes of Using Mycophenolate Mofetil Monotherapy in Substitution for Calcineurin Inhibitors in Liver Transplantation - Conquest Health • Nosocomial lower respiratory tract infections in patients with immunosuppression: a cohort study - Incacare • Time is spine: critical updates for the intensivist - Incacare • Update on tocilizumab in rheumatoid arthritis: a narrative review - Conquest Health • Tacrolimus levels and variability in CKD and ESRD risk post-liver transplant - Conquest Health • Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline - Incacare • The Role of Semaphorins in the Pathogenesis of Rheumatoid Arthritis - Conquest Health • Recurrent Urinary Tract Infections (UTIs): A Review and Proposal for Clinicians - Incacare • Time in therapeutic range of tacrolimus in allogeneic hematopoietic stem cell transplant recipients is associated with acute graft-versus-host disease prophylaxis - Conquest Health • Risk factors for colonisation by Multidrug-Resistant bacteria in critical care units - Incacare • New Perspectives on Antimicrobial Agents: Rezafungin - Incacare • Future of non-invasive graft evaluation: A systematic review of proteomics in kidney transplantation - Conquest Health • Current role of ceftobiprole in the treatment of hospital acquired and community acquired pneumonia: expert opinion based on literature and real-life experiences - Incacare • Prediction of sepsis among patients with major trauma using artificial intelligence: a multicenter validated cohort study - Incacare • Machine Perfusion in Deceased Donor Kidney Transplantation: Editorial Summary of a Cochrane Review - Conquest Health • The Surgical Infection Society Guidelines on the Management of Intra-Abdominal Infection - Incacare • Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis - Incacare • Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM - Incacare • Harnessing of Artificial Intelligence for the Diagnosis and Prevention of Hospital-Acquired Infections: A Systematic Review - Incacare • Understanding antimicrobial pharmacokinetics in critically ill patients to optimize antimicrobial therapy: A narrative review - Incacare • New Perspectives on Antimicrobial Agents: Isavuconazole - Incacare • Novel Approaches to Immunomodulation for Solid Organ Transplantation - Conquest Health • Progress in medical therapy in aplastic anemia: why it took so long? - Conquest Health • Identification of early risk factors for anti-citrullinated-protein-antibody positive rheumatoid arthritis - A prospective cohort study - Conquest Health • Kidney Function Decline and Serious Adverse Drug Reactions in CKD Patients | Conquest Health • Diagnostic limitations and challenges in current clinical guidelines and potential application of metagenomic sequencing to manage pulmonary invasive fungal infections in patients with haematological malignancies - Incacare • Lung ultrasound and supine chest X-ray use in modern adult intensive care: mapping 30 years of advancement (1993–2023) - Incacare • Changes in Cognitive Function After Kidney Transplantation: A Longitudinal Cohort Study - Conquest Health • High-dose amphotericin: yay or nay? A case series and literature review - Incacare • Predictors at diagnosis for start of biologic disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis: A cohort study - Conquest Health • Meeting the Therapeutic Challenges of Emergent and Rare Invasive Fungal Diseases Through Novel Clinical Trial Designs - Incacare • Organ Donation - Conquest Health • Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia - Conquest Health • The Integration of Technology and Innovation in the Development of Patient-Centered Medicine in the Intensive Care Unit: A Literature Review - Incacare • Risk factors and mortality rates of carbapenem-resistant Gram-negative bacterial infections in intensive care units - Incacare • Role of PET/CT in diagnosing and monitoring disease activity in rheumatoid arthritis: A review - Conquest Health • New Antibiotics for the Treatment of Nosocomial Central Nervous System Infections - Incacare • The Treatment of Acute Antibody-Mediated Rejection in Kidney Transplant Recipients A Systematic Review - Conquest Health • Micromotor-based dual aptassay for early cost-effective diagnosis of neonatal sepsis - Incacare • Optimising the Treatment of Invasive Candidiasis – A Case for Combination Therapy - Incacare • Clinical recommendations for the inpatient management of lower respiratory tract infections in children and adolescents with severe neurological impairment - Incacare • Patient-reported treatment response in chronic graft-versus-host disease - Conquest Health • Management of Bacterial and Fungal Infections in the ICU: Diagnosis, Treatment, and Prevention Recommendations - Incacare • Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial - Conquest Health • Towards non-invasive diagnostic techniques for early detection of acute renal transplant rejection: A review - Conquest Health • Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort - Conquest Health • Minimization of Transplant Immunosuppression: An Elusive Goal - Conquest Health • Sepsis-associated acute kidney injury treatment standard - Incacare • Extracorporeal blood purification therapies for sepsis-associated acute kidney injury in critically ill patients: expert opinion from the SIAARTI-SIN joint commission - Incacare • Rejection markers in kidney transplantation: do new technologies help children? - Conquest Health • A Novel Therapeutic Strategy for Aplastic Anemia by The Good Health Conquest • How to Use Nebulized Antibiotics in Severe Respiratory Infections - Incacare • Bacterial Pathogens Causing Pneumonia Post Hematopoietic Stem Cell Transplant: The Chronic GVHD Population - Conquest Health • Nebulized Antibiotics in Severe Respiratory Infections by The Good Health Conquest • Advances in the treatment of invasive fungal disease - Incacare • Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis - Conquest Health • Current Therapies in Kidney Transplant Rejection - Conquest Health • Understanding Non-Alcoholic Fatty Liver Disease: A Silent Threat by The Good Health Conquest • Ep 23. Changes in Intestinal Metabolic Profile in Kidney Transplant Recipients with Antibody-Mediated Rejection by The Good Health Conquest • Advancements of next generation sequencing in the field of Rheumatoid Arthritis - Conquest Health • The Good Health Conquest - RNA based therapeutic to treat human fungal infections. • The Good Health Conquest - The use of smart environments and robots for infection prevention control. • Ep 19. Novel therapeutic approaches to invasive Candidiasis by The Good Health Conquest • JAK inhibitors in rheumatology - Conquest Health • Ep 17. International guidelines for management of sepsis and septic shock by The Good Health Conquest • Novel strategies in nephrology: what to expect from the future? - Conquest Health • The Management of Infectious Pulmonary Processes in the Emergency Department - Incacare • Ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam activities against multidrug-resistant Enterobacterales from United States Medical Centers (2018–2022) - Incacare • Efficacy of combined immunosuppression with or without eltrombopag in children with newly diagnosed aplastic anemia - Conquest Health • The use of smart environments and robots for infection prevention control: A systematic literature review - Incacare • Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments - Conquest Health • Novel Therapeutic Approaches to Invasive Candidiasis: Considerations for the Clinician - Incacare • Mass Cytometry Analysis Identifies T Cell Immune Signature of Aplastic Anemia and Predicts the Response to Cyclosporine - Conquest Health • Ep 13. Systemic Lupus Erythematosus: New Diagnostic and Therapeutic Approaches by The Good Health Conquest • Ep 9. Dose-response Relationship between Glucocorticoid Tapering & risk of Flare in RA patients by The Good Health Conquest • Association Between Novel Hematological Indices and Measures of Disease Activity in Patients with Rheumatoid Arthritis - Conquest Health • Utility of plasma cell-free DNA next-generation sequencing for diagnosis of infectious diseases in patients with hematological disorders - Incacare • The Gut Microbiota in Kidney Transplantation: A Target for Personalized Therapy? - Conquest Health • Podcast Ep 10. New Drugs for the treatment of Pseudomonas aeruginosa infections by The Good Health Conquest • Recent advances in critical care: Part II - Incacare • Podcast Ep 7. Revolutionizing Rheumatoid Arthritis treatment with Nanovaccines by The Good Health Conquest • Podcast Ep 6. Management of Chronic Kidney Transplant Rejection by The Good Health Conquest • Carbapenem-resistant gram-negative bacterial infection in intensive care unit patients: Antibiotic resistance analysis and predictive model development - Incacare • Pericardial Effusion: A Novel Presentation of Aplastic Anemia - Conquest Health • Podcast - Ep 5. Role of Nebulized Colistin as a substitutive strategy against nosocomial pneumonia caused by CR-GNB by The Good Health Conquest • Nanotechnology-Based Approaches for Voriconazole Delivery Applied to Invasive Fungal Infections - Incacare • Ruxolitinib on acute graft-versus-host disease prophylaxis after modified donor lymphocyte infusion - Conquest Health • Altered lipid metabolism in synovial fibroblasts of individuals at risk of developing rheumatoid arthritis - Conquest Health • The Latest Updates in Nephrology and Organ Transplant - Conquest Health • Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs) - Conquest Health • KRA CME Webinar Registration Link • How to use biomarkers of infection or sepsis at the bedside: guide to clinicians - Incacare • Seeking Standardized Definitions for HLA-incompatible Kidney Transplants: A Systematic Review - Conquest Health • Intensive Care Unit Physicians’ Perspectives on Artificial Intelligence–Based Clinical Decision Support Tools: Preimplementation Survey Study - Incacare • Novel, Innovative Models to Study Ischemia/Reperfusion-Related Redox Damage in Organ Transplantation - Conquest Health • Role of nebulized colistin as a substitutive strategy against nosocomial pneumonia caused by CR-GNB in intensive care units: a retrospective cohort study - Incacare • Effect of Maintaining Immunosuppression After Kidney Allograft Failure on Mortality and Retransplantation - Conquest Health • Diagnosis and management of fungal infections in solid organ transplant recipients in South Asia - Incacare • Robots and Intelligent Medical Devices in the Intensive Care Unit: Vision, State of the Art and Economic Analysis - Incacare • Clonality in immune aplastic anemia: Mechanisms of immune escape or malignant transformation - Conquest Health • A multisite evaluation of antifungal use in critical care: implications for antifungal stewardship - Incacare • Cancers after hematopoietic cell transplantation for aplastic anemia—the importance of persistence - Conquest Health • New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review - Incacare • Chronic Kidney Transplant Rejection - Conquest Health • Filgotinib, a novel JAK1-preferential inhibitor for the treatment of rheumatoid arthritis: An overview from clinical trials - Conquest Health • From vaccines to nanovaccines: A promising strategy to revolutionize rheumatoid arthritis treatment - Conquest Health • Novel and Improved Methods for the Prevention and Treatment of Graft-Versus-Host Disease - Conquest Health • New Microbiological Techniques for the Diagnosis of Bacterial Infections and Sepsis in ICU Patients - Incacare • Systematic review of quantitative preference studies of treatments for rheumatoid arthritis among patients and at-risk populations - Conquest Health • Critical care ultrasound goal-directed versus early goal-directed therapy in septic shock - Incacare • Eltrombopag in Frontline Therapy for Severe Aplastic Anemia: A RACE Against Time - Conquest Health • When to change treatment of acute invasive aspergillosis: an expert viewpoint - Incacare • Therapeutic Drug Monitoring of Antifungal Agents in Critically Ill Patients: Is There a Need for Dose Optimisation? - Incacare • RITUXIMAB VERSUS TOCILIZUMAB IN RHEUMATOID ARTHRITIS: SYNOVIAL BIOPSY-BASED BIOMARKER ANALYSIS OF THE PHASE 4 R4RA RANDOMIZED TRIAL • RNA-BASED THERAPEUTICS TO TREAT HUMAN FUNGAL INFECTIONS • A NEW AGE IN MOLECULAR DIAGNOSTIC FOR INVASIVE FUNGAL • Know More - Organ Donation • ASSOCIATION OF INTRAINDIVIDUAL TACROLIMUS VARIABILITY WITH DE NOVO DONOR-SPECIFIC HLA ANTIBODY DEVELOPMENT AND ALLOGRAFT REJECTION IN PEDIATRIC KIDNEY TRANSPLANT • INFUSION OF HAPLOIDENTICAL HEMATOPOIETIC STEM CELLS COMBINED WITH MESENCHYMAL STEM CELLS FOR THE TREATMENT OF SEVERE APLASTIC ANEMIA IN ADULT PATIENTS YIELDS CURATIVE EFFECTS • NONINVASIVE TESTING AND SURROGATE MARKERS IN INVASIVE FUNGAL DISEASES • A NEW STANDARD IMMUNOSUPPRESSION REGIMEN IN SEVERE APLASTIC ANEMIA • NEBULIZED AMPHOTERICIN B IN MECHANICALLY VENTILATED COVID-19 PATIENTS TO PREVENT INVASIVE PULMONARY ASPERGILLOSIS • BREAKING THE BARRIERS TO INNOVATION IN KIDNEY CARE • ISAVUCONAZOLE AND LAMB COMBINATION THERAPY FOR INVASIVE CANDIDIASIS • NEXT LEVEL OF HOSPITALIZATION THROUGH SMART ICU • EXPERIENCE OF ISAVUCONAZOLE AS A SALVAGE THERAPY IN CHRONIC PULMONARY FUNGAL DISEASE • INTERACTION BETWEEN POSACONAZOLE & FLUCLOXACILLIN IN A LUNG TRANSPLANT PATIENT: DECREASE IN PLASMA EXPOSURE OF POSACONAZOLE & POSSIBLE UNDERTREATMENT OF INVASIVE ASPERGILLOSIS: CASE REPORT • ASSOCIATION BETWEEN ENZYME-LINKED IMMUNOSORBENT ASSAY-MEASURED KIDNEY INJURY MARKERS AND URINARY CADMIUM LEVELS IN CHRONIC KIDNEY DISEASE • CHRONIC KIDNEY DISEASE AND RISK MANAGEMENT: STANDARDS OF MEDICAL CARE IN DIABETES—2022 • OUTCOMES AND PREDICTORS OF SKIN SODIUM CONCENTRATION IN DIALYSIS PATIENTS • OPTIMISED VERSUS STANDARD AUTOMATED PERITONEAL DIALYSIS REGIMENS PILOT STUDY (OPTISTAR): A RANDOMISED CONTROLLED CROSSOVER TRIAL • SAFETY AND EFFICACY OF DOACS IN PATIENTS WITH ADVANCED AND END-STAGE RENAL DISEASE • COMPUTATIONAL PREDICTION OF BIOMARKERS, PATHWAYS, AND NEW TARGET DRUGS IN THE PATHOGENESIS OF IMMUNE-BASED DISEASES REGARDING KIDNEY TRANSPLANTATION REJECTION • THE APPLICATION OF NANOPARTICLES IN DIAGNOSIS AND TREATMENT OF KIDNEY DISEASES • RECOMMENDATIONS FOR LONG-TERM OUTCOMES IN SEPSIS AND SEPTIC SHOCK: A COMPARISON BETWEEN JAPANESE AND INTERNATIONAL GUIDELINES • CSR INITIATIVE - CONCORD BIOTECH AND FUEL TO PROVIDE STEM COACHING AND STEM EDUCATION • INNOVATIONS IN INFECTIOUS DISEASE TESTING: LEVERAGING COVID-19 PANDEMIC TECHNOLOGIES FOR THE FUTURE • QUANTIFICATION OF TORQUE TENO VIRUS (TTV) DNA IN SALIVA AND PLASMA SAMPLES IN PATIENTS AT SHORT TIME BEFORE AND AFTER KIDNEY TRANSPLANTATION • EMERGING FUNGAL INFECTIONS: NEW SPECIES, NEW NAMES, AND ANTIFUNGAL RESISTANCE • CELL-FREE DNA DIAGNOSTICS IN TRANSPLANTATION UTILIZING NEXT GENERATION SEQUENCING • REAL-WORLD USE OF ISAVUCONAZOLE AS PRIMARY THERAPY FOR INVASIVE FUNGAL INFECTIONS IN HIGH-RISK PATIENTS WITH HEMATOLOGIC MALIGNANCY OR STEM CELL TRANSPLANT • ADRENAL FUNCTION TESTING IN DIALYSIS PATIENTS A REVIEW OF THE LITERATURE • UPDATES FROM THE WORLD HEALTH ORGANIZATION WHO ON GLOBAL TREATMENT RECOMMENDATIONS FOR DRUG SUSCEPTIBLE AND MULTIDRUG RESISTANT TUBERCULOSIS • 23RD INTERNATIONAL CONFERENCE ON DIALYSIS: ADVANCES IN CHRONIC KIDNEY DISEASE 2021 • EFFICACY AND SAFETY OF INTRAVENOUS FOSFOMYCIN FOR THE TREATMENT OF DIFFICULT-TO-TREAT GRAM-NEGATIVE BACTERIAL INFECTIONS • REDUCING KIDNEY FUNCTION DECLINE IN PATIENTS WITH CKD: CORE CURRICULUM 2021 • GUIDANCE ON IMAGING FOR INVASIVE PULMONARY ASPERGILLOSIS AND MUCORMYCOSIS • ANTAGONISTS IN CKD: IN NEED OF A FEW LARGE TRIALS • REAL-WORLD ASSESSMENT OF THE EFFECTIVENESS OF POSACONAZOLE FOR THE PROPHYLAXIS AND TREATMENT OF INVASIVE FUNGAL INFECTIONS IN HEMATOLOGICAL PATIENTS • BIORESPONSIVE MICRO-TO-NANO ALBUMIN-BASED SYSTEMS FOR TARGETED DRUG DELIVERY AGAINST COMPLEX FUNGAL INFECTIONS • EVOLUTION OF TECHNIQUES IN ROBOTIC KIDNEY TRANSPLANTATION WITH PERSPECTIVES ON FUTURE DEVELOPMENTS • EXPERT CONSENSUS STATEMENTS FOR THE MANAGEMENT OF COVID-19-RELATED ACUTE RESPIRATORY FAILURE USING A DELPHI METHOD • A LARGE RETROSPECTIVE ASSESSMENT OF VORICONAZOLE EXPOSURE IN PATIENTS TREATED WITH EXTRACORPOREAL MEMBRANE OXYGENATION • NEW MICROBIOLOGICAL TECHNIQUES FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS AND SEPSIS IN ICU PATIENTS • UPDATE ON THE MANAGEMENT OF UROLOGICAL PROBLEMS FOLLOWING KIDNEY TRANSPLANTATION • KIDNEY ORGANOID SYSTEMS FOR STUDIES OF IMMUNE-MEDIATED KIDNEY DISEASES: CHALLENGES AND OPPORTUNITIES • IBREXAFUNGERP, A NOVEL ORAL TRITERPENOID ANTIFUNGAL IN DEVELOPMENT: OVERVIEW OF ANTIFUNGAL ACTIVITY AGAINST CANDIDA GLABRATA • TACKLING CHRONIC KIDNEY TRANSPLANT REJECTION: CHALLENGES AND PROMISES • COMBINATION OF MESENCHYMAL STROMAL CELLS AND MACHINE PERFUSION AS A NOVEL STRATEGY FOR ORGAN PRESERVATION IN SOLID ORGAN TRANSPLANTATION • PRECISION MEDICINE APPROACHES FOR DIABETIC KIDNEY DISEASE: OPPORTUNITIES AND CHALLENGES • CONTINUATION OF PERITONEAL DIALYSIS IN ADULT KIDNEY TRANSPLANT RECIPIENTS WITH DELAYED GRAFT FUNCTION • CURRENT APPROACHES TO DESENSITIZATION IN SOLID ORGAN TRANSPLANTATION • RECOMBINANT PROTEIN VACCINES, A PROVEN APPROACH AGAINST CORONAVIRUS PANDEMICS • CLINICAL EFFICACY AND PHARMACOKINETICS OF COLISTIMETHATE SODIUM AND COLISTIN IN CRITICALLY ILL PATIENTS IN AN INDIAN HOSPITAL • POST-TRANSPLANTATION PLASMA MALONDIALDEHYDE IS ASSOCIATED WITH CARDIOVASCULAR MORTALITY IN RENAL TRANSPLANT RECIPIENTS: A PROSPECTIVE COHORT STUDY • COVID-19 INFECTION IN KIDNEY TRANSPLANT RECIPIENTS: DISEASE INCIDENCE AND CLINICAL OUTCOMES • PHARMACOKINETICS OF HIGH-DOSE TIGECYCLINE IN CRITICALLY ILL PATIENTS WITH SEVERE INFECTIONS • NEW POTENTIAL BIOMARKERS FOR CHRONIC KIDNEY DISEASE MANAGEMENT- A REVIEW OF THE LITERATURE • RECENT ADVANCES AND CLINICAL OUTCOMES OF KIDNEY TRANSPLANTATION • PERFORMING BRONCHOSCOPY IN TIMES OF THE COVID-19 PANDEMIC: PRACTICE STATEMENT FROM AN INTERNATIONAL EXPERT PANEL • UPDATE ON RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN KIDNEY TRANSPLANTATION • DIAGNOSTIC VALUE OF TWEAK FOR PREDICTING ACTIVE LUPUS NEPHRITIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS • COMPARISON OF COMPLETE RENAL RESPONSE AND MORTALITY IN EARLY- AND LATE-ONSET LUPUS NEPHRITIS: A MULTICENTER RETROSPECTIVE STUDY OF A JAPANESE COHORT • PROLONGED VERSUS INTERMITTENT BETA-LACTAM ANTIBIOTICS INTRAVENOUS INFUSION STRATEGY IN SEPSIS OR SEPTIC SHOCK PATIENTS • EPIDEMIOLOGY, PATHOPHYSIOLOGY AND MANAGEMENT OF LUPUS NEPHRITIS • BASIC CRITICAL CARE FOR MANAGEMENT OF COVID-19 PATIENTS: POSITION PAPER OF THE INDIAN SOCIETY OF CRITICAL CARE MEDICINE, PART II • DISCUSSING LUPUS NEPHRITIS: DIAGNOSIS, SYMPTOMS, TREATMENTS • DE-ESCALATION OF ANTIMICROBIAL THERAPY IN ICU SETTINGS WITH HIGH PREVALENCE OF MULTIDRUG RESISTANT BACTERIA • URINARY ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE (ALCAM) AS A NOVEL BIOMARKER OF LUPUS NEPHRITIS HISTOLOGY • MANAGEMENT OF INVASIVE CANDIDIASIS AND CANDIDAEMIA IN CRITICALLY ILL ADULTS • Recurrence of Hepatocellular Carcinoma in HCV Liver Transplant Recipients Treated with Direct-Acting Antiviral (DAA) Therapy - Conquest Health • Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors - Conquest Health • Hepatitis C viraemic organs in solid organ transplantation - Conquest Health • Pre and Post Transplant Management of Hepatitis C - Conquest Health • Improving Global Kidney Health - Conquest Health • Living well with kidney disease by patient and care partner empowerment - Conquest Health • Management of invasive candidiasis and candidaemia in critically ill adults - Incacare • COVID-19: implications for immunosuppression in kidney disease and transplantation - Conquest Health • A New Age in Molecular Diagnostics for Invasive Fungal Disease - Incacare • Systematic review of safety and efficacy of COVID-19 vaccines in patients with kidney disease • Increased susceptibility to intensive care unit acquired pneumonia - Incacare • Chronic kidney diseases- Recent advances in clinical and basic research - Conquest Health • Review of influenza associated pulmonary aspergillosis in ICU patients • Advances in CKD 2020 • Recent Advances in diagnosing chronic pulmonary Aspergillosis • KIDNEY DISEASE AND ALL-CAUSE MORTALITY IN PATIENTS WITH COVID-19 HOSPITALIZED IN GENOA, NORTHERN ITALY • Aspergillosis complicating severe coronavirus • CKD is a key risk factor for COVID-19 mortality • Hope on the Horizon: Novel Fungal Treatments in Development • CKD and COVID-19 mortality